|
|
Volumn 33, Issue 2, 2008, Pages 111-131
|
|
Branch retinal vein occlusion: Pathogenesis, visual prognosis, and treatment modalities
|
|
Author keywords
Branch retinal vein occlusion; Pathogenesis; Risk factors; Treatment; Visual prognosis
|
|
Indexed keywords
ACTIVATED PROTEIN C;
ANTITHROMBIN;
ANTIVITAMIN K;
BEVACIZUMAB;
DEXAMETHASONE;
DEXTRAN;
HEPARIN;
PHOSPHOLIPID ANTIBODY;
PLACEBO;
POSURDEX;
PROTHROMBIN;
RANIBIZUMAB;
TICLOPIDINE;
TRIAMCINOLONE ACETONIDE;
TROXERUTIN;
UNCLASSIFIED DRUG;
ANTITHROMBIN DEFICIENCY;
ARTERIOVENOUS FISTULA;
ARTERY CONSTRICTION;
BLOOD VESSEL WALL;
BRANCH RETINAL VEIN OCCLUSION;
CHI SQUARE TEST;
CONJUNCTIVAL HEMORRHAGE;
CONJUNCTIVAL HYPEREMIA;
FIBRINOLYSIS;
GENE MUTATION;
HEMATOLOGIC DISEASE;
HEMODILUTION;
HUMAN;
HYPERHOMOCYSTEINEMIA;
LASER COAGULATION;
LOW LEVEL LASER THERAPY;
NERVE SHEATH;
PATHOGENESIS;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN C DEFICIENCY;
PROTEIN S DEFICIENCY;
RETINA MACULA EDEMA;
SHORT SURVEY;
VISUAL ACUITY;
VITRECTOMY;
BASEMENT MEMBRANE;
DECOMPRESSION, SURGICAL;
HUMANS;
PROGNOSIS;
RETINAL VEIN OCCLUSION;
VISUAL ACUITY;
VITRECTOMY;
|
|
EID: 39749193519
PISSN: 02713683
EISSN: 14602202
Source Type: Journal
DOI: 10.1080/02713680701851902 Document Type: Short Survey |
|
Times cited : (359)
|
|
References (150)
|
